Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myron J Levin

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Vaccines|May 7, 2025
The Reduced Immunogenicity of Zoster Vaccines in CMV-Seropositive Older Adults Correlates with T Cell ImprintingAdriana Weinberg, Thao Vu, Michael J Johnson, et al.
AIDS Research and Human Retroviruses|March 21, 2006
Cytomegalovirus-specific cell-mediated immunity in HIV-infected children on HAARTAdriana Weinberg, Andrew A Wiznia, Bonnie J Lafleur, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 1, 2010
Prevention strategies for herpes zoster and post-herpetic neuralgiaMyron J Levin, Anne A Gershon, Robert H Dworkin, et al.
Clinical Microbiology Reviews|January 15, 2003
Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapyTeresa H Bacon, Myron J Levin, Jeffry J Leary, et al.
Rheumatology (Oxford, England)|September 10, 2020
Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trialsAlemnew F Dagnew, Debora Rausch, Caroline Hervé, et al.
The Journal of Infectious Diseases|December 1, 2021
Cell-Mediated Immune Responses After Administration of the Live or the Recombinant Zoster Vaccine: 5-Year PersistenceMichael J Johnson, Cuining Liu, Debashis Ghosh, et al.
The Journal of Infectious Diseases|January 19, 2007
DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccineVladimir N Loparev, Elena Rubtcova, Jane F Seward, et al.
Open Forum Infectious Diseases|July 16, 2016
Cost of Herpes Zoster in Patients With Selected Immune-Compromised Conditions in the United StatesQian Li, Shih-Yin Chen, Stuart J Burstin, et al.
Journal of Virology|March 25, 2021
Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster VaccinesD Scott Schmid, Congrong Miao, Jessica Leung, et al.
Open Forum Infectious Diseases|March 4, 2015
Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United StatesJose A Suaya, Shih-Yin Chen, Qian Li, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Vaccines|May 7, 2025
The Reduced Immunogenicity of Zoster Vaccines in CMV-Seropositive Older Adults Correlates with T Cell ImprintingAdriana Weinberg, Thao Vu, Michael J Johnson, et al.
AIDS Research and Human Retroviruses|March 21, 2006
Cytomegalovirus-specific cell-mediated immunity in HIV-infected children on HAARTAdriana Weinberg, Andrew A Wiznia, Bonnie J Lafleur, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 1, 2010
Prevention strategies for herpes zoster and post-herpetic neuralgiaMyron J Levin, Anne A Gershon, Robert H Dworkin, et al.
Clinical Microbiology Reviews|January 15, 2003
Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapyTeresa H Bacon, Myron J Levin, Jeffry J Leary, et al.
Rheumatology (Oxford, England)|September 10, 2020
Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trialsAlemnew F Dagnew, Debora Rausch, Caroline Hervé, et al.
The Journal of Infectious Diseases|December 1, 2021
Cell-Mediated Immune Responses After Administration of the Live or the Recombinant Zoster Vaccine: 5-Year PersistenceMichael J Johnson, Cuining Liu, Debashis Ghosh, et al.
The Journal of Infectious Diseases|January 19, 2007
DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccineVladimir N Loparev, Elena Rubtcova, Jane F Seward, et al.
Open Forum Infectious Diseases|July 16, 2016
Cost of Herpes Zoster in Patients With Selected Immune-Compromised Conditions in the United StatesQian Li, Shih-Yin Chen, Stuart J Burstin, et al.
Journal of Virology|March 25, 2021
Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster VaccinesD Scott Schmid, Congrong Miao, Jessica Leung, et al.
Open Forum Infectious Diseases|March 4, 2015
Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United StatesJose A Suaya, Shih-Yin Chen, Qian Li, et al.
Pageof 19